Abstract:The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway is an evolving DNA-sensing mechanism involved in innate immunity and pathogen defense that has been optimized while remaining conserved. Aside from recognizing pathogens through conserved motifs, these receptors also detect aberrant or misplaced self-molecules as possible signs of perturbed homeostasis. Upon binding external or self-derived DNA, a mobile secondary messenger 2′3′-cyclic GMP-AMP (cGAMP) is produced by cGAS and in turn activates its adapter STING in the endoplasmic reticulum (ER). Resting-state or activated STING protein is finely restricted by multiple degradation machineries. The post-translational changes of the STING protein, along with the regulatory machinery of the secret routes, limit the onset, strength and sustention of STING signal. STING experiences a conformational shift and relocates with TBK1 from the ER to perinuclear vesicles containing transcription factors, provoking the transcription activity of IRF3/IFN-I and NF-κB pathways, as well as to initiate a number of cellular processes that have been shown to alter the immune landscape in cancer, such as autophagy, NLRP3 inflammasome, ER stress, and cell death. STING signal thus serves as a potent activator for immune mobilization yet also triggers immune-mediated pathology in tissues. Recent advances have established the vital role of STING in immune surveillance as well as tumorigenic process. This review provides an overview of the disparate outcomes of cancer attributed to the actions of pleiotropic and coordinated STING downstream signalosomes, along with the underlying mechanisms of STING function in pathologies, providing therapeutic implications for new approaches in hunt for the next generation of cancer immunotherapy base on STING.

Insight into the Dichotomous Regulation of STING Activation in Immunotherapy

cGAS-STING signaling pathway in gastrointestinal inflammatory disease and cancers

Cell-to-cell communications of cGAS-STING pathway in tumor immune microenvironment.

Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies

Activation of Stimulation of Interferon Genes (STING) Signal and Cancer Immunotherapy

Trapping microfluidic drops in wells of surface energy.

Mini-review: the distinct roles of STING signaling in tumor immunity-recent progress

Immune Regulation of the cGAS-STING Signaling Pathway in the Tumor Microenvironment and Its Clinical Application

Advances in the Prerequisite and Consequence of STING Downstream Signalosomes

Clinical applications of STING agonists in cancer immunotherapy: current progress and future prospects

Strategies involving STING pathway activation for cancer immunotherapy: mechanism and agonists

Targeting STING signaling for the optimal cancer immunotherapy

The cGAS/STING Pathway: A Novel Target for Cancer Therapy

Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS-STING pathway strategies

cGAS-STING pathway in cancer biotherapy

Chemical Biology Perspectives on STING Agonists as Tumor Immunotherapy

cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors

STING-mediated DNA sensing in cancer immunotherapy

Bidirectional regulation of the cGAS-STING pathway in the immunosuppressive tumor microenvironment and its association with immunotherapy

IUPHAR ECR review: The cGAS-STING pathway: Novel functions beyond innate immune and emerging therapeutic opportunities

Epigenetic regulation of cGAS and STING expression in cancer